Other
Neoplasm of Uncertain Malignant Potential
CI-CAN-00000035Explore in graph →
Non-malignant8 active trials
- NCIt
- C3646
Loading cancer entity…
Other
CI-CAN-00000035Explore in graph →
Clinical trials
115 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01116154 | Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma | terminated | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Dec 9, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Dec 9, 2010source: clinicaltrials